Scpharmaceuticals Drug Patent Portfolio
Scpharmaceuticals owns 1 orange book drug protected by 3 US patents Given below is the list of Scpharmaceuticals's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272064 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
| US11433044 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
| US9884039 | Pharmaceutical formulations for subcutaneous administration of furosemide | 03 Apr, 2034 | Active |
Latest Legal Activities on Scpharmaceuticals's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Scpharmaceuticals.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 21 Jan, 2023 | US9884039 |
| Mail Certificate of Correction Memo | 20 Jan, 2023 | US9884039 |
| Certificate of Correction Memo | 18 Jan, 2023 | US9884039 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 31 Oct, 2022 | US10272064 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 Sep, 2022 | US11433044 |
|
Recordation of Patent Grant Mailed
Critical
| 06 Sep, 2022 | US11433044 |
|
Email Notification
Critical
| 18 Aug, 2022 | US11433044 |
|
Issue Notification Mailed
Critical
| 17 Aug, 2022 | US11433044 |
| Dispatch to FDC | 28 Jul, 2022 | US11433044 |
|
Application Is Considered Ready for Issue
Critical
| 28 Jul, 2022 | US11433044 |
|
Issue Fee Payment Received
Critical
| 26 Jul, 2022 | US11433044 |
|
Issue Fee Payment Verified
Critical
| 26 Jul, 2022 | US11433044 |
|
Electronic Review
Critical
| 28 Apr, 2022 | US11433044 |
|
Mail Notice of Allowance
Critical
| 28 Apr, 2022 | US11433044 |
|
Email Notification
Critical
| 28 Apr, 2022 | US11433044 |
Scpharmaceuticals's Family Patents
Scpharmaceuticals drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 25.0% of its total global patent coverage. Click
below to unlock the full patent family tree.
Scpharmaceuticals Drug List
Given below is the complete list of Scpharmaceuticals's drugs and the patents protecting them.
1. Furoscix
Furoscix is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10272064 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(9 years from now)
| Active |
| US11433044 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(9 years from now)
| Active |
| US9884039 | Pharmaceutical formulations for subcutaneous administration of furosemide |
03 Apr, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Furoscix's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List